Azanta Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $27.6M

Azanta General Information

Description

Operator of a privately-owned specialty pharma company intended to offer treatments for women's health indications and orphan oncology. The company's portfolio of specialty pharmaceutical products includes Nimorazole, a hypoxic radiosensitizer for the treatment of head and neck cancer patients undergoing primary radiotherapy and Angusta for labour induction, enabling women to get health and addiction medicine products easily.

Contact Information

Website
www.azanta.com
Formerly Known As
IPC International
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Gearhalsvej 1
  • 2500 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Gearhalsvej 1
  • 2500 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azanta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 24-Mar-2020 $27.6M Completed Generating Revenue
4. Later Stage VC 02-Oct-2015 Completed Generating Revenue
3. Debt - General 14-Oct-2014 Completed Generating Revenue
2. Early Stage VC 01-Jul-2009 $33.7M $42.8M Completed Generating Revenue
1. Early Stage VC 01-Jun-2008 $9.1M $9.1M Completed Generating Revenue
To view Azanta’s complete valuation and funding history, request access »

Azanta Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Azanta’s complete cap table history, request access »

Azanta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a privately-owned specialty pharma company intended to offer treatments for women's health indications and o
Drug Discovery
Copenhagen, Denmark
2 As of 2022

Rahway, NJ
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Azanta Competitors (52)

One of Azanta’s 52 competitors is Merck & Co., a Corporation company based in Rahway, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Rahway, NJ
Damora Therapeutics ( Drug Discovery) Formerly VC-backed Waltham, MA
Nexoplex bio Formerly VC-backed Emeryville, CA
Emmaus Life Sciences Formerly VC-backed Torrance, CA
Gilead Formerly VC-backed Foster City, CA
You’re viewing 5 of 52 competitors. Get the full list »

Azanta Patents

Azanta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016004960-A2 Misoprostol dispersible tablet Inactive 11-Jul-2014
WO-2016004960-A3 Misoprostol dispersible tablet Inactive 11-Jul-2014
CA-2888856-A1 Dispersible tablet Inactive 19-Nov-2012
EP-2919754-A1 Dispersible tablet Inactive 19-Nov-2012
US-20150283083-A1 Dispersible tablet Inactive 19-Nov-2012 A61K9/2077
To view Azanta’s complete patent history, request access »

Azanta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azanta Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dansk Erhvervsinvestering Venture Capital Minority
Eaton Corporation Minority
European Equity Partners Venture Capital Minority
IPCons Corporation Minority
Sunstone Life Science Ventures Venture Capital Minority
To view Azanta’s complete investors history, request access »

Azanta Acquisitions (1)

Azanta’s most recent deal was a Merger/Acquisition with NatImmune for . The deal was made on 26-Jun-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NatImmune 26-Jun-2009 Merger/Acquisition Drug Discovery
To view Azanta’s complete acquisitions history, request access »

Azanta Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
NatImmune Copenhagen, Denmark 2000

Azanta FAQs

  • When was Azanta founded?

    Azanta was founded in 2004.

  • Where is Azanta headquartered?

    Azanta is headquartered in Copenhagen, Denmark.

  • What is the size of Azanta?

    Azanta has 2 total employees.

  • What industry is Azanta in?

    Azanta’s primary industry is Drug Discovery.

  • Is Azanta a private or public company?

    Azanta is a Private company.

  • What is the current valuation of Azanta?

    The current valuation of Azanta is .

  • What is Azanta’s current revenue?

    The current revenue for Azanta is .

  • How much funding has Azanta raised over time?

    Azanta has raised $58.7M.

  • Who are Azanta’s investors?

    Dansk Erhvervsinvestering, Eaton, European Equity Partners, IPCons, and Sunstone Life Science Ventures have invested in Azanta.

  • Who are Azanta’s competitors?

    Merck & Co., Damora Therapeutics ( Drug Discovery), Nexoplex bio, Emmaus Life Sciences, and Gilead are some of the 52 competitors of Azanta.

  • When was Azanta acquired?

    Azanta was acquired on 24-Mar-2020.

  • Who acquired Azanta?

    Azanta was acquired by Norgine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process